FOXO3 and hepatocellular carcinoma: Purified vitexin compound 1 (VB-1) inhibited the proliferation of HCC cells and also reduced the secretion of VEGF, inhibited the formation of endothelial tubules, and inhibited the growth and angiogenesis of HCC by inactivating Akt and activating FOXO3a [133].